Edition:
United Kingdom

NanJing Pharmaceutical Co Ltd (600713.SS)

600713.SS on Shanghai Stock Exchange

4.43CNY
14 Dec 2018
Change (% chg)

¥-0.07 (-1.56%)
Prev Close
¥4.50
Open
¥4.47
Day's High
¥4.49
Day's Low
¥4.42
Volume
1,494,900
Avg. Vol
2,348,306
52-wk High
¥6.49
52-wk Low
¥4.21

Latest Key Developments (Source: Significant Developments)

NanJing Pharmaceutical issues 2018 fourth tranche super short-term financing notes worth 500 mln yuan
Tuesday, 17 Jul 2018 

July 17(Reuters) - NanJing Pharmaceutical Co Ltd <600713.SS>:Says it issued 2018 fourth tranche super short-term financing notes worth 500 million yuan, with a term of 270 days and interest rate of 4.76 percent.  Full Article

NanJing Pharmaceutical issues 2018 third tranche super short-term financing notes worth 500 mln yuan
Friday, 13 Jul 2018 

July 13(Reuters) - NanJing Pharmaceutical Co Ltd <600713.SS>:Says it issued 2018 third tranche super short-term financing notes worth 500 million yuan, with a term of 36 days and interest rate of 4.48 percent.  Full Article

NanJing Pharmaceutical to acquire 51 pct stake in medical firm for 23 mln yuan
Friday, 13 Jul 2018 

July 13(Reuters) - NanJing Pharmaceutical Co Ltd <600713.SS>:Says it plans to acquire 51 percent stake in a medical company for 23 million yuan .  Full Article

NanJing Pharmaceutical issues 2018 second tranche super short-term financing notes worth 500 mln yuan
Wednesday, 20 Jun 2018 

June 20 (Reuters) - NanJing Pharmaceutical Co Ltd <600713.SS>:Says it issued 2018 second tranche super short-term financing notes worth 500 million yuan with a term of 28 days and coupon rate of 4.7 percent .Industrial Bank Co., Ltd., served as the main underwriter.  Full Article

NanJing Pharmaceutical issues 2018 first tranche super short-term financing notes worth 500 mln yuan
Thursday, 17 May 2018 

May 17 (Reuters) - NanJing Pharmaceutical Co Ltd <600713.SS>:Says it issued 2018 first tranche super short-term financing notes worth 500 million yuan with a term of 180 days and coupon rate of 4.88 percent .Bank of Communications Co., Ltd served as the main underwriter .  Full Article

Nanjing Pharmaceutical and unit plan two PBM project JVs
Monday, 11 Dec 2017 

Dec 11 (Reuters) - Nanjing Pharmaceutical Co Ltd <600713.SS>:Says it will invest 2 million yuan to set up a Jiangsu-based PBM (medical benefit management)business JV and hold 40 percent stake in the JV after transaction .Says Nanjing-based pharmaceutical unit will invest 3 million yuan to set up a Nanjing-based PBM related pharmacy JV and hold 60 percent stake in the JV after transaction .  Full Article

NanJing Pharmaceutical to set up two units and two branches for regional network construction
Friday, 24 Nov 2017 

Nov 24 (Reuters) - NanJing Pharmaceutical Co Ltd <600713.SS> ::Says it plans to use 30 million yuan to set up wholly owned Changzhou unit and 20 million yuan to set up wholly owned Taizhou unit as well as two branches in Zhenjiang and Lianyungang for regional distribution network construction.  Full Article

NanJing Pharmaceutical unit to set up smart elder care center in Hefei
Monday, 30 Oct 2017 

Oct 30(Reuters) - NanJing Pharmaceutical Co Ltd <600713.SS>:Says co's Anhui-based unit and Anhui-based hospital will jointly invest 60 million yuan to set up smart elder care center firm in Hefei .  Full Article

NanJing Pharmaceutical acquires stake in three medicine related firms
Monday, 30 Oct 2017 

Oct 30(Reuters) - NanJing Pharmaceutical Co Ltd <600713.SS>:Says it acquired 20 percent stake in Jiang Su Hua Xiao Pharmal Euhcal Lugisinls Co Ltd.Says it acquired 20 percent stake in Nanjing Pharmaceurical Nantong Kambridge Co Ltd.Says it acquired 39.8 percent stake in Nanjing Pharmaceurical (Huaian) Tianyi Ltd.Says it fully acquired the three firms .  Full Article

NanJing Pharmaceutical signs cooperation agreement on pharmacy benefit management project
Thursday, 26 Oct 2017 

Oct 26 (Reuters) - NanJing Pharmaceutical Co Ltd <600713.SS>:Says it signed cooperation agreement with a community health service center of Nanjing on Oct. 24.Says two entities mainly cooperate on pharmacy benefit management project .  Full Article